Human CD164 Protein (CD6-HM204)
$216.00 – $720.00
KACTUS Biosystems Human CD164 Protein (CD6-HM204) (catalog No. CD6-HM204) is expressed from HEK293 with hFc tag at the C-Terminus.It contains Asp24-Asp162.
- Details & Specifications
- References
- More Offers
| Catalog No. | CD6-HM204 |
|---|---|
| Product Name | Human CD164 Protein (CD6-HM204) |
| Supplier Name | KACTUS Biosystems |
| Brand Name | KACTUS Biosystems |
| Synonyms | MUC-24; Endolyn; MGC-24; Cd164; CD164; MGC-24v; sialomucin |
| Species | Human |
| Source | HEK293 |
| Accession | Q04900-1 |
| Product Tag | C-hFc |
| Biotinylated | no |
| Exact Sequence | Asp24-Asp162 |
| Molecular Weight | The protein has a predicted MW of 41.2 kDa. Due to glycosylation, the protein migrates to 110-115 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Endotoxin | Less than 1EU per μg by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.；-20 to -80°C for 3-6 months in unopened state after reconstitution.；2-8°C for 2-7 days after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
CD6-HM204: Human CD164 Protein (CD6-HM204)
CD164 was found to play a role in many malignant diseases. CD164 was associated with clinical and pathological features of patients. High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients.CD164 was associated with the poor clinical outcomes of BC patients. Silencing of CD164 could inhibit the progression of tumors in vivo and in vitro, which may become an effective target in the treatment of bladder cancer.
Please remember our product information: Human CD164 Protein (CD6-HM204) catalog number: CD6-HM204 KACTUS Biosystems
